Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrence Hepatocellular Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00019604
What this trial is testing

Radiofrequency Ablation in Treating Patients With Unresectable Primary or Metastatic Liver Cancer

Who this might be right for
Liver CancerMetastatic CancerUnspecified Adult Solid Tumor, Protocol Specific
National Institutes of Health Clinical Center (CC) 44
Post-approval studies (Phase 4)Looking for participantsNCT06717919
What this trial is testing

HOPE Against Cancer Recurrence in HCC

Who this might be right for
Liver TransplantationHCCOncological Outcomes
Philipp Dutkowski 220
Not applicableUnknownNCT02525965
What this trial is testing

The Influence of Resection Margin on the Recurrence of Early-stage Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital 194
Not applicableUnknownNCT04552236
What this trial is testing

Evaluation of Liver Stiffness by Ultrasound Elastography for Predicting Early HCC Recurrence After Treatment

Who this might be right for
Hepatocellular Carcinoma
Assiut University 100
Testing effectiveness (Phase 2)Ended earlyNCT01229111
What this trial is testing

Cediranib Maleate and Combination Chemotherapy in Treating Patients With Advanced Biliary Cancers

Who this might be right for
Adult Primary Cholangiocellular CarcinomaAdvanced Adult Primary Liver CancerCholangiocarcinoma of the Extrahepatic Bile Duct+8 more
National Cancer Institute (NCI) 14
Large-scale testing (Phase 3)UnknownNCT04392700
What this trial is testing

A RCT of TNF and ENT in the Treatment of Long-term Prognosis With Hepatitis B-related HCC After Curative Resection

Who this might be right for
Hepatocellular Carcinoma Recurrent
Sun Yat-sen University 706
Early research (Phase 1)Ended earlyNCT04187872
What this trial is testing

LITT and Pembrolizumab in Recurrent Brain Metastasis

Who this might be right for
MelanomaNon-small Cell Lung Carcinoma (NSCLC)Renal Cell Carcinoma (RCC)+12 more
University of Florida 10
Large-scale testing (Phase 3)Looking for participantsNCT06644937
What this trial is testing

Single-arm Clinical Trial of TACE in Combination With Icaritin as Adjuvant Therapy After Surgery in Patients With Hepatocellular Carcinoma at High Risk of Recurrence

Who this might be right for
Hepatocellular Carcinoma (HCC)
Zhujiang Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00956930
What this trial is testing

Chemoembolization Versus Radioembolization in Treating Patients With Liver Cancer That Cannot Be Treated With Radiofrequency Ablation Or Surgery

Who this might be right for
Liver Cancer
Northwestern University 45
Large-scale testing (Phase 3)Study completedNCT00355862
What this trial is testing

Immunosuppression in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
University of Regensburg 525
Not applicableLooking for participantsNCT05866783
What this trial is testing

Serum Glycomics as Prognostic and Diagnostic Biomarkers of Disease Recurrence in Liver Transplant Recipients With Hepatocellular Carcinoma

Who this might be right for
Prognostic BiomarkerLiver TransplantationDiagnostic Biomarker+1 more
University Hospital, Ghent 500
Testing effectiveness (Phase 2)Study completedNCT00019760
What this trial is testing

Isolated Hepatic Perfusion With Melphalan Followed By Chemotherapy in Treating Patients With Unresectable Colorectal Cancer That is Metastatic to the Liver

Who this might be right for
Recurrent Colon CancerLiver MetastasesStage IV Rectal Cancer+2 more
National Institutes of Health Clinical Center (CC)
Testing effectiveness (Phase 2)Study completedNCT00019331
What this trial is testing

Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors

Who this might be right for
Colorectal CancerEndometrial CancerHead and Neck Cancer+6 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT06812039
What this trial is testing

HAIC Combined with Donafenib and Sintilimab As Perioperative Treatment for Resectable Hepatocellular Carcinoma Patients At High Risk of Recurrence

Who this might be right for
Hepato Cellular Carcinoma (HCC)
Fudan University 165
Testing effectiveness (Phase 2)Looking for participantsNCT06265285
What this trial is testing

Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program

Who this might be right for
Advanced Esophageal Squamous Cell CarcinomaAdvanced Renal Cell CarcinomaClinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8+28 more
Mayo Clinic 50
Testing effectiveness (Phase 2)Study completedNCT00553332
What this trial is testing

Selumetinib in Treating Patients With Biliary Cancer That Cannot Be Removed By Surgery

Who this might be right for
Liver and Intrahepatic Biliary Tract CancerRecurrent Extrahepatic Bile Duct CancerUnresectable Extrahepatic Bile Duct Cancer
National Cancer Institute (NCI) 29
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07644208
What this trial is testing

PD-1/IL-2 Bispecific Antibody as Neoadjuvant Therapy for Early Recurrent Hepatocellular Carcinoma After Curative Hepatectomy

Who this might be right for
Hepatocellular Carcinoma (HCC)
Shanghai Zhongshan Hospital 30
Not applicableStudy completedNCT02859753
What this trial is testing

Comparison of Response and Recurrence Rates Following Percutaneous Microwave Coagulation Therapy Versus Percutaneous Radiofrequency Ablation

Who this might be right for
ThermoablationChronic Liver DiseaseHepatocellular Carcinoma
Centre Hospitalier Universitaire Dijon 35
Not applicableUnknownNCT05572528
What this trial is testing

Lenvatinib Therapy in HCC Patients After LDLT

Who this might be right for
Liver TransplantationHepatocellular Carcinoma
Kaoshiung Chang Gung Memorial Hospital 30
Not applicableStudy completedNCT06720675
What this trial is testing

Ex-vivo Hypotermic Perfusion in Patients With Hepatocellular Carcinoma to Reduce the Incidence of Tumor Recurrence

Who this might be right for
Liver CarcinomaLiver TransplantTumor Recurrence+2 more
IRCCS Azienda Ospedaliero-Universitaria di Bologna 237
Next Page